[HTML][HTML] Changes in glycolytic pathway in SARS-COV 2 infection and their importance in understanding the severity of COVID-19

AF Santos, P Póvoa, P Paixão, A Mendonça… - Frontiers in …, 2021 - frontiersin.org
COVID-19 is an infectious disease caused by Coronavirus 2 (SARS-CoV-2) that may lead to
a severe acute respiratory syndrome. Such syndrome is thought to be related, at least in …

[HTML][HTML] N-acetylcysteine for prevention and treatment of COVID-19: current state of evidence and future directions

JL Izquierdo-Alonso, S Pérez-Rial, CG Rivera… - Journal of infection and …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes
coronavirus disease 2019 (COVID-19) and can be associated with serious complications …

Where are we with the use of N-acetylcysteine as a preventive and adjuvant treatment for COVID-19?

F Di Marco, G Foti, AG Corsico - European Review for Medical and …, 2022 - air.unimi.it
OBJECTIVE: As N-acetylcysteine (NAC) is promising as a re-purposed drug for the
adjunctive or supportive treatment of serious COVID-19, this article aimed to describe …

N‐Acetylcysteine and Other Sulfur‐Donors as a Preventative and Adjunct Therapy for COVID‐19

HN du Preez, C Aldous, HG Kruger… - Advances in …, 2022 - Wiley Online Library
The airway epithelial glycocalyx plays an important role in preventing severe acute
respiratory syndrome coronavirus 2 entry into the epithelial cells, while the endothelial …

[HTML][HTML] Challenges in ARDS definition, management, and identification of effective personalized therapies

D Battaglini, B Fazzini, PL Silva, FF Cruz, L Ball… - Journal of Clinical …, 2023 - mdpi.com
Over the last decade, the management of acute respiratory distress syndrome (ARDS) has
made considerable progress both regarding supportive and pharmacologic therapies. Lung …

Evaluation the efficacy and safety of N‐acetylcysteine inhalation spray in controlling the symptoms of patients with COVID‐19: An open‐label randomized controlled …

Y Panahi, M Ghanei, M Rahimi, A Samim… - Journal of Medical …, 2023 - Wiley Online Library
The aim of this study was to evaluate the effect and safety of N‐acetylcysteine (NAC)
inhalation spray in the treatment of patients with coronavirus disease 2019 (COVID‐19). This …

[HTML][HTML] Use of thiols in the treatment of COVID-19: current evidence

M Cazzola, P Rogliani, SS Salvi, J Ora, MG Matera - Lung, 2021 - Springer
There is a possible role for oxidative stress, a state characterized by an altered balance
between the production of free radicals or reactive oxygen species (ROS) and antioxidant …

[HTML][HTML] N-acetylcysteine reduces severity and mortality in COVID-19 patients: A systematic review and meta-analysis

MS Alam, MN Hasan, Z Maowa, F Khatun… - Journal of advanced …, 2023 - ncbi.nlm.nih.gov
Objectives: Recent clinical studies suggest that oxidative stress is one of the key players in
the pathogenesis of coronavirus disease 2019 (COVID-19), and N-acetylcysteine (NAC), a …

[HTML][HTML] Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated …

CW Kuo, PL Su, TH Huang, CC Lin, CW Chen… - Scientific reports, 2023 - nature.com
Alveolar macrophages (AMs) are the drivers of pulmonary cytokine storm in severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate …

[HTML][HTML] Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19: A systematic review

EE Tsermpini, U Glamočlija, F Ulucan-Karnak… - Antioxidants, 2022 - mdpi.com
The coronavirus disease (COVID-19) pandemic is a leading global health and economic
challenge. What defines the disease's progression is not entirely understood, but there are …